The Optimal Composition of Influenza Vaccines Subject to Random Production Yields

References

• Anderson R. M., May R. M.Infectious Diseases of Humans: Dynamics and Control (1991) (Oxford University Press, New York) Crossref, Google Scholar
• Andreasen V., Lin J., Levin S. A. The dynamics of cocirculating influenza strains conferring partial cross-immunity. J. Math. Biology (1997) 35(7):825–842Crossref, Google Scholar
• Bailey N. T. J.The Mathematical Theory of Infectious Diseases and Its Applications (1975) (Griffin, London) Google Scholar
• Brito D. L., Sheshinski E., Intriligator M. D. Externalities and compulsory vaccinations. J. Public Econom. (1991) 45(1):69–90Crossref, Google Scholar
• Centers for Disease Control and Prevention Influenza (flu). (2007a) . Retrieved October 20, 2007, http://www.cdc.gov/fluGoogle Scholar
• Centers for Disease Control and Prevention (CDC) 2007–2008 influenza vaccine production and distribution. (2007b) . http://www2a.cdc.gov/podcasts/media/pdf/PanFluVodcast9-07.pdfGoogle Scholar
• Centers for Disease Control and Prevention (CDC) Seasonal influenza vaccine supply for the U.S. 2008–09 influenza season. (2008) . Retrieved September 26, 2008, http://www.cdc.gov/flu/about/qa/vaxsupply.htmGoogle Scholar
• Chick S. E., Mamani H., Simchi-Levi D. Supply chain coordination and influenza vaccination. Oper. Res. (2008) 56(6):1493–1506Link, Google Scholar
• Cohen M. A., Eliashberg J., Ho T. New product development: The performance and time-to-market tradeoff. Management Sci. (1996) 42(2):173–186Link, Google Scholar
• Deo S., Corbett C. J. Cournot competition under yield uncertainty: The case of the U.S. influenza vaccine market. Manufacturing Service Oper. Management (2009) 11(4):563–571Link, Google Scholar
• Earn D., Dushoff J., Levin S. A. Ecology and evolution of the flu. TRENDS Ecology Evolution (2002) 17(7):334–340Crossref, Google Scholar
• Federgruen A., Yang N. Selecting a portfolio of suppliers under demand and supply risks. Oper. Res. (2008) 56(4):916–936Link, Google Scholar
• General Accounting Office Flu vaccine: Supply problems heighten need to ensure access for high-risk people. (2001) . Report to Congressional Requesters, General Accounting Office, Washington, DC. http://www.gao.gov/new.items/d01624.pdfGoogle Scholar
• Health Industry Distributors Association 2006–2007 influenza vaccine production and distribution. (2007) . http://www.flusupplynews.com/documents/06-07FluBrief.pdf-FINAL.pdfGoogle Scholar
• Hill A. N., Longini I. M. The critical vaccination fraction for heterogeneous epidemic models. Math. Biosciences (2003) 181(1):85–106Crossref, Google Scholar
• Jefferson T., Rivetti D., Rivetti A., Rudin M., Di Pietrantonj C., Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: A systematic review. Lancet (2005) 366(9492):1165–1174Crossref, Google Scholar
• Kornish L. J., Keeney R. L. Repeated commit-or-defer decisions with a deadline: The influenza vaccine composition. Oper. Res. (2008) 56(3):527–541Link, Google Scholar
• Levandowski R. A. Options for influenza composition 2005–2006. (2005) Presentation, Vaccines and Related Biological Products Advisory CommitteeFebruary 16–17(Food and Drug Administration, Silver Spring, MD) . http://www.fda.gov/ohrms/dockets/AC/05/slides/2005-4087S1_8.pptGoogle Scholar
• Matthews J. T. Egg-based production of influenza vaccine: 30 years of commercial experience. The Bridge (2006) 36(3):17–24Google Scholar
• McCardle K. F. Information acquisition and the adoption of new technology. Management Sci. (1985) 31(11):1372–1389Link, Google Scholar
• Morgan L. O., Morgan R. M., Moore W. L. Quality and time-to-market trade-offs when there are multiple product generations. Manufacturing Service Oper. Management (2001) 3(2):89–104Link, Google Scholar
• Morris W. T.Management Science: A Bayesian Introduction (1968) (Prentice-Hall, Upper Saddle River, NJ) Google Scholar
• Nichol K. L. The efficacy, effectiveness, and cost-effectiveness of inactivated influenza virus vaccines. Vaccine (2003) 21(16):1769–1775Crossref, Google Scholar
• O'Mara D., Fukuda K., Singleton J. A. Influenza vaccine: Ensuring timely and adequate supply. Infect. Med. (2003) 20(11):548–554Google Scholar
• Özer Ö., Uncu O. Optimizing dynamic time-to-market and production decisions for a component supplier. (2006) . Working paper, Stanford University, Stanford, CAGoogle Scholar
• Philipson T., Culyer A. J., Newhouse J. P. Economic epidemiology and infectious diseases. Handbook of Health Economics (2003) 1B(Elsevier Science, Amsterdam) 1761–1799Google Scholar
• Sanofi Pasteur Sanofi Pasteur awarded $97 million HHS contract to accelerate cell-culture pandemic influenza vaccine development. (2005) . Press release (April 1)Google Scholar
• Sanofi Pasteur Sanofi Pasteur awarded contract to retrofit influenza vaccine facility. (2007) . Press release (June 14)Google Scholar
• Souza G. C., Bayus B. L., Wagner H. M. New-product strategy and industry clockspeed. Management Sci. (2004) 50(4):537–549Link, Google Scholar
• Ulu C., Smith J. E. Uncertainty, information acquisition, and technology adoption. Oper. Res. (2008) 57(3):740–752Link, Google Scholar
• Vaccines and Related Biological Products Advisory Committee (Committee) Transcripts and other meeting documents. 2002–2007Retrieved February 21, 2007, http://www.fda.gov/cber/advisory/vrbp/vrbpmain.htmGoogle Scholar
• Vaccines and Related Biological Products Advisory Committee (Committee) 94th Meeting (February 20). (2003) . Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/ohrms/dockets/AC/03/transcripts/3922t1.docGoogle Scholar
• Vaccines and Related Biological Products Advisory Committee (Committee) 97th Meeting (February 19). (2004) . Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/ohrms/dockets/AC/04/transcripts/4020t2.docGoogle Scholar
• World Health Organization Influenza vaccines: WHO position paper. Weekly Epidemiological Record (2005) 33:277–288Google Scholar
• World Health Organization Influenza. (2007) . Retrieved February 21, 2007, http://www.who.int/immunization/topics/influenza/en/Google Scholar
• Wu J. T., Wein L. M., Perelson A. S. Optimization of influenza vaccine selection. Oper. Res. (2005) 53(3):456–476Link, Google Scholar
• Yano C. A, Lee H. L. Lot sizing with random yields: A review. Oper. Res. (1995) 43(2):311–334Link, Google Scholar